Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Sell
17
AMIX Quote, Financials, Valuation and Earnings
Last price:
$0.60
Seasonality move
:
-36.54%
Day range:
$0.62 - $0.67
52-week range:
$0.60 - $4.58
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
0.64x
Volume:
108.8K
Avg. volume:
10.8M
1-year change:
-82.09%
Market cap:
$4.1M
Revenue:
--
EPS (TTM):
-$5.19
Analysts' Opinion
-
Consensus RatingAutonomix Medical, Inc. has received a consensus rating of Buy. The company's average rating is a Buy based on 1 Buy rating, 0 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $6.60, Autonomix Medical, Inc. has an estimated upside of 923.73% from its current price of $0.64.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $5.00 representing 100% downside risk from its current price of $0.64.
Fair Value
-
According to the consensus of 1 analyst, Autonomix Medical, Inc. has 923.73% upside to fair value with a price target of $6.60 per share.
AMIX vs. S&P 500
-
Over the past 5 trading days, Autonomix Medical, Inc. has underperformed the S&P 500 by -4.66% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Autonomix Medical, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Autonomix Medical, Inc. has grown year-over-year revenues for 0 quarters straight. In the most recent quarter Autonomix Medical, Inc. reported revenues of --.
Earnings Growth
-
Autonomix Medical, Inc. has grown year-over-year earnings for 5 quarters straight. In the most recent quarter Autonomix Medical, Inc. reported earnings per share of -$1.38.
Enterprise value:
-3M
EV / Invested capital:
-0.47x
Price / LTM sales:
--
EV / EBIT:
--
EV / Revenue:
--
PEG ratio (5yr expected):
--
EV / Free cash flow:
0.27x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
-$100K
Return On Assets:
-189.42%
Net Income Margin (TTM):
--
Return On Equity:
-243.23%
Return On Invested Capital:
-228.46%
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -$134K | -$100K | -$45K | -$2K | |
| Operating Income | -$3.3M | -$10.9M | -$17M | -$2.8M | -$7.5M | |
| EBITDA | -$3.3M | -$10.8M | -$16.9M | -$2.8M | -$7.5M | |
| Diluted EPS | -$8.62 | -$14.13 | -$5.19 | -$2.47 | -$1.38 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | -- | -- | $2.2M | $5.4M | $7.9M | |
| Total Assets | -- | -- | $2.4M | $5.4M | $7.9M | |
| Current Liabilities | -- | -- | $437.5K | $1.3M | $1.5M | |
| Total Liabilities | -- | -- | $5.3M | $2.3M | $1.5M | |
| Total Equity | -- | -- | -$2.9M | $3M | $6.4M | |
| Total Debt | -- | -- | $61.7K | $1.1M | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -- | -$8.3M | -$11.2M | -$1.6M | -$3.8M | |
| Cash From Investing | -- | -$40K | -$9K | -- | -- | |
| Cash From Financing | -- | $11.3M | $13.6M | -- | $2.6M | |
| Free Cash Flow | -- | -$8.3M | -$11.2M | -$1.6M | -$3.8M | |
AMIX
Sector
Market Cap
$4.1M
$28.4M
Price % of 52-Week High
13.13%
51.17%
Dividend Yield
0%
0%
Shareholder Yield
-161.56%
-1.49%
1-Year Price Total Return
-82.09%
-16.67%
Beta (5-Year)
--
0.518
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$0.66
200-day SMA
Sell
Level
$1.37
Bollinger Bands (100)
Sell
Level
0.86 - 1.2
Chaikin Money Flow
Sell
Level
-136M
20-day SMA
Sell
Level
$0.82
Relative Strength Index (RSI14)
Sell
Level
36.05
ADX Line
Sell
Level
20.79
Williams %R
Buy
Level
-86.7965
50-day SMA
Sell
Level
$0.93
MACD (12, 26)
Sell
Level
-0.09
25-day Aroon Oscillator
Sell
Level
-84
On Balance Volume
Neutral
Level
409.7M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (-8.5894)
Sell
CA Score
(Annual)
Level (-4.4412)
--
Beneish M-Score
(Annual)
Level (--)
Sell
Momentum Score
Level (1)
Sell
Ohlson Score
Level (14.4714)
--
Piotroski F Score
(Annual)
Level (--)
Sell
Quality Ratio Score
Level (1)
Sell
Fundamental Score
Level (2)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Autonomix Medical, Inc. is a development stage medical device development company focused on advancing innovative technologies for sensing and treating disorders relating to the nervous system. Its technology platform includes a catheter-based microchip-enabled array that can detect and differentiate neural signals with a high degree of sensitivity as demonstrated in animal studies. The company was founded by Robert Schwartz, Landy Toth, David A. Robins, and Robert A. Van Tassel on June 10, 2014 and is headquartered in The Woodlands, TX.
Stock Forecast FAQ
In the current month, AMIX has received 1 Buy ratings 0 Hold ratings, and 0 Sell ratings. The AMIX average analyst price target in the past 3 months is $6.60.
-
Where Will Autonomix Medical, Inc. Stock Be In 1 Year?
According to analysts, the consensus estimate is that Autonomix Medical, Inc. share price will rise to $6.60 per share over the next 12 months.
-
What Do Analysts Say About Autonomix Medical, Inc.?
Analysts are divided on their view about Autonomix Medical, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Autonomix Medical, Inc. is a Sell and believe this share price will drop from its current level to $5.00.
-
What Is Autonomix Medical, Inc.'s Price Target?
The price target for Autonomix Medical, Inc. over the next 1-year time period is forecast to be $6.60 according to 1 Wall Street analyst, 1 of them rates the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is AMIX A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Autonomix Medical, Inc. is a Buy. 1 of 1 analysts rates the stock a Buy at this time.
-
How Can I Buy Shares Of AMIX?
You can purchase shares of Autonomix Medical, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Autonomix Medical, Inc. shares.
-
What Is The Autonomix Medical, Inc. Share Price Today?
Autonomix Medical, Inc. was last trading at $0.60 per share. This represents the most recent stock quote for Autonomix Medical, Inc.. Yesterday, Autonomix Medical, Inc. closed at $0.64 per share.
-
How To Buy Autonomix Medical, Inc. Stock Online?
In order to purchase Autonomix Medical, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get AMIX Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
AMIX
Sector
P/E ratio
--
23.89x
PEG ratio
--
-0.01x
P/B ratio
0.64x
1.81x
Price / LTM sales
--
1.58x
Growth Metrics
AMIX
Sector
Revenue growth
--
4.62%
Earnings growth
44.21%
10.7%
Revenue (5-year growth)
--
6.5%
Earnings forecast
--
-$0.21
Profitability
AMIX
Sector
Profitability FY 2024
-$183K
$3.6M
Return on invested capital
-228.46%
-31.84%
Return on assets
-189.42%
-27.96%
Return on equity
-243.23%
-37.63%
Earnings Date
Last Earnings Date
Dec
24
Next Earnings Date
Dec
24
Estimated Next Earnings Date
Mar
25
Balance Sheet
AMIX
Sector
Total cash
$7.5M
$26.4M
Short term investments
--
$25.7M
Total assets
$9.8M
$76.9M
Long term debt
--
$3.3M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Is Bloom Energy The Best Stock to Buy Now?
Shares of energy startup Bloom Energy (NYSE:BE) have advanced by…
Stock Ideas
Buy
55
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 63x
Buy
53
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 36x
Buy
59
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
60
AAOI alert for Dec 23
Applied Optoelectronics, Inc. [AAOI] is up 3.95% over the past day.
Buy
60
ZBIO alert for Dec 23
Zenas BioPharma, Inc. [ZBIO] is up 1.18% over the past day.
Buy
54
UNF alert for Dec 23
UniFirst Corp. [UNF] is up 0.77% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
